Theravance, Inc. (NASDAQ:THRX)

CAPS Rating: 2 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.

Recs

0
Player Avatar Brian7992 (< 20) Submitted: 8/20/2009 7:40:30 AM : Outperform Start Price: $15.66 THRX Score: +8.01

Best Bio Bets

Featured Broker Partners


Advertisement